Pharma and Biotech
EPS Growth shows the relative growth of a company's earnings over the last year.
The rise in total monies receivable for goods / services sold before expenses.
1yr EPS Growth |
---|
1yr Revenue Growth |
---|
The percentage of the share price that a company pays out as dividends over a year.
The percentage change from the previous year in the dividend paid on each share.
Dividend Yield |
---|
1yr DPS Growth |
---|
The share price as a ratio of revenue per share.
The share price as a ratio of net asset value.
Price Sales Ratio |
---|
Price Book Ratio |
---|
In percentage total change in share price over 30 days.
In percentage total change in share price over 3 months.
Price Chg 30d |
---|
Price Chg 3m |
---|
The Relative Strength Index measures a share price relative to itself and its recent history.
Momentum is an oscillator that measures the rate of price change.
RSI |
---|
Momentum 20 |
---|
Operating Margin is profit as a percentage of sales.
Return on capital employed measures the return from invested and borrowed capital.
Operating Margin |
---|
ROCE |
---|
Earnings per share, the company's profitability expressed on a per share basis.
Analysts' estimates of future EPS for the next 2 years.
EPS |
---|
Forecast EPS |
---|
Monies produced from sales of goods and services after trade discounts, VAT, etc.
Operating Profit is the profit after deducting operating costs from gross profits.
Turnover |
---|
Operating Profit Loss |
---|
The difference between current assets and current liabilities.
A current asset representing the company's financial liquidity.
Assets |
---|
Cash |
---|
The cumulative amount of stocks sold by company directors over 1 year
The cumulative amount of stocks bought by company directors over 1 year
Sells 1y |
---|
Buys 1y |
---|
The percentage of stockbrokers that rate the company as a Buy
The percentage of stockbrokers that rate the company as a Hold
Brokers Percent Buy |
---|
Brokers Percent Neutral |
---|
Currency | UK Pounds |
Share Price | 35.60p |
Change Today | -3.40p |
% Change | -8.72 % |
52 Week High | 48.00p |
52 Week Low | 34.00p |
Volume | 118,205 |
Shares Issued | 739.79m |
Market Cap | £263.37m |
Beta | 0.48 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:45 | 3 @ 35.64p |
12:40 | 44 @ 36.00p |
11:41 | 5,682 @ 36.00p |
11:41 | 6,318 @ 36.00p |
11:38 | 7,236 @ 35.61p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research